Liaudet L - Search Results

1

Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis.

Mukhopadhyay P, Rajesh M, Cao Z, Horváth B, Park O, Wang H, Erdelyi K, Holovac E, Wang Y, Liaudet L, Hamdaoui N, Lafdil F, Haskó G, Szabo C, Boulares AH, Gao B, Pacher P. Mukhopadhyay P, et al. Among authors: liaudet l. Hepatology. 2014 May;59(5):1998-2009. doi: 10.1002/hep.26763. Epub 2014 Apr 1. Hepatology. 2014. PMID: 24089324 Free PMC article.

2

A new, potent poly(ADP-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging.

Pacher P, Vaslin A, Benko R, Mabley JG, Liaudet L, Haskó G, Marton A, Bátkai S, Kollai M, Szabó C. Pacher P, et al. Among authors: liaudet l. J Pharmacol Exp Ther. 2004 Nov;311(2):485-91. doi: 10.1124/jpet.104.069658. Epub 2004 Jun 22. J Pharmacol Exp Ther. 2004. PMID: 15213249 Free PMC article.

3

Beneficial effects of a novel ultrapotent poly(ADP-ribose) polymerase inhibitor in murine models of heart failure.

Pacher P, Liaudet L, Mabley JG, Cziráki A, Haskó G, Szabó C. Pacher P, et al. Among authors: liaudet l. Int J Mol Med. 2006 Feb;17(2):369-75. Int J Mol Med. 2006. PMID: 16391839 Free PMC article.

4

Pharmacological inhibition of poly(ADP-ribose) polymerase inhibits angiogenesis.

Rajesh M, Mukhopadhyay P, Bátkai S, Godlewski G, Haskó G, Liaudet L, Pacher P. Rajesh M, et al. Among authors: liaudet l. Biochem Biophys Res Commun. 2006 Nov 17;350(2):352-7. doi: 10.1016/j.bbrc.2006.09.049. Epub 2006 Sep 20. Biochem Biophys Res Commun. 2006. PMID: 17007818 Free PMC article.

5

Poly(ADP-ribose)polymerase inhibition decreases angiogenesis.

Rajesh M, Mukhopadhyay P, Godlewski G, Bátkai S, Haskó G, Liaudet L, Pacher P. Rajesh M, et al. Among authors: liaudet l. Biochem Biophys Res Commun. 2006 Dec 1;350(4):1056-62. doi: 10.1016/j.bbrc.2006.09.160. Epub 2006 Oct 9. Biochem Biophys Res Commun. 2006. PMID: 17046715 Free PMC article.

6

Poly(ADP-ribose) polymerases as modulators of mitochondrial activity.

Bai P, Nagy L, Fodor T, Liaudet L, Pacher P. Bai P, et al. Among authors: liaudet l. Trends Endocrinol Metab. 2015 Feb;26(2):75-83. doi: 10.1016/j.tem.2014.11.003. Epub 2014 Dec 9. Trends Endocrinol Metab. 2015. PMID: 25497347 Review.

7

PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis.

Mukhopadhyay P, Horváth B, Rajesh M, Varga ZV, Gariani K, Ryu D, Cao Z, Holovac E, Park O, Zhou Z, Xu MJ, Wang W, Godlewski G, Paloczi J, Nemeth BT, Persidsky Y, Liaudet L, Haskó G, Bai P, Boulares AH, Auwerx J, Gao B, Pacher P. Mukhopadhyay P, et al. Among authors: liaudet l. J Hepatol. 2017 Mar;66(3):589-600. doi: 10.1016/j.jhep.2016.10.023. Epub 2016 Oct 29. J Hepatol. 2017. PMID: 27984176

8

The role of poly(ADP-ribose) polymerase activation in the development of myocardial and endothelial dysfunction in diabetes.

Pacher P, Liaudet L, Soriano FG, Mabley JG, Szabó E, Szabó C. Pacher P, et al. Among authors: liaudet l. Diabetes. 2002 Feb;51(2):514-21. doi: 10.2337/diabetes.51.2.514. Diabetes. 2002. PMID: 11812763

9

Activation of poly(ADP-Ribose) polymerase-1 is a central mechanism of lipopolysaccharide-induced acute lung inflammation.

Liaudet L, Pacher P, Mabley JG, Virág L, Soriano FG, Haskó G, Szabó C. Liaudet L, et al. Am J Respir Crit Care Med. 2002 Feb 1;165(3):372-7. doi: 10.1164/ajrccm.165.3.2106050. Am J Respir Crit Care Med. 2002. PMID: 11818323

10

Endothelial dysfunction in aging animals: the role of poly(ADP-ribose) polymerase activation.

Pacher P, Mabley JG, Soriano FG, Liaudet L, Komjáti K, Szabó C. Pacher P, et al. Among authors: liaudet l. Br J Pharmacol. 2002 Mar;135(6):1347-50. doi: 10.1038/sj.bjp.0704627. Br J Pharmacol. 2002. PMID: 11906946 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

235 results

Search Page